Innovation Labs to Enhance Collaboration

NCT05395286 | Completed Results

• 1 other identifier: STUDY00001360
• Study Type: interventional
• Target: 94
• Locations: 1 country
• Sites: 1

Brief Summary

Conduct and evaluate the impact of two week-long Innovation Labs on collaboration attitudes and behavior among early career scholars. Applicants to each Innovation Lab will be screened and then randomized to either the Innovation Lab group or a control group.

Conditions

Collaboration Attitudes and Behavior

Outcome Measures

Primary Outcomes (4)

• MATRICx Collaboration Benefits/Motivators Scale

  Self-report: The Motivation Assessment for Team Readiness, Integration, and Collaboration (MATRICx; Mallinson, Lotrecchiano, et al., 2016) benefits scale includes 17 items that tap into perceived motivators/benefits of collaboration. Each is rated on a 1-4 scale. Scale scores were computed as the mean of all 17 items, for a benefits scale score ranging from 1-4, with higher scores indicating greater collaboration readiness.

  15 months

• MATRICx Collaboration Barriers/Threats Scale

  Self-report: The Motivation Assessment for Team Readiness, Integration, and Collaboration (MATRICx; Mallinson, Lotrecchiano, et al., 2016) Threats Scale includes 31 barriers to -- or threats of -- collaboration. Each is rated on a 1-4 scale. Scale scores were computed as the mean of all 31 items, for a Barriers/Threats scale score ranging from 1-4, with lower scores indicating greater collaboration readiness.

  15 months

• Transdisciplinary Orientation Scale

  Self-report: The Transdisciplinary Orientation scale (TDO; Misra, Stokols, \& Cheng, 2015) is a 12-item scale that measures values, attitudes, and beliefs, and conceptual skills and behaviors, that assesses the degree to which participants are oriented towards transdisciplinary collaboration. Items are rated on a five-point scale (1="Strongly Disagree," 5="Strongly Agree"). The total score is the mean of all 12 items, with a resulting 1-5 range, in which higher scores indicate greater transdisciplinary collaboration orientation.

  15 months

• Collaboration Network Size

  Objective number of collaborators from published articles on PubMed

  36 Months (18-monts pre- and post-treatment, after excluding articles published within +/-3 months of the Innovation Lab)

Secondary Outcomes (5)

• Self-Reported Number of Grants Submitted Per Year

  21 months (9 months pre-treatment [obtained at baseline and EOT]; 12 months post-treatment [obtained at 6- and 12-month follow-up])

• ILab Met Goal - New Collab

  12 months (End of Treatment [3 months post-baseline], 6-Month Follow-Up [9 months post-baseline], and 12-Month Follow-Up [15 months post-baseline])

• ILab Met Goal - Novel Proposals

  12 months (End of Treatment [3 months post-baseline], 6-Month Follow-Up [9 months post-baseline], and 12-Month Follow-Up [15 months post-baseline])

• ILab - Recommend

  12 months (End of Treatment [3 months post-baseline], 6-Month Follow-Up [9 months post-baseline], and 12-Month Follow-Up [15 months post-baseline])

• ILab - Positive Impact

  12 months (End of Treatment [3 months post-baseline], 6-Month Follow-Up [9 months post-baseline], and 12-Month Follow-Up [15 months post-baseline])

Study Arms (2)

Innovation Lab Group

EXPERIMENTAL

Randomized to attend the Innovation Lab

Behavioral: Innovation Lab

Control Group

NO INTERVENTION

Randomized to NOT attend the Innovation Lab

Interventions

Innovation Lab BEHAVIORAL

An Innovation Lab is a facilitated 5-day residential event designed to create novel, transdisciplinary and potentially transformative research ideas and proposals to address a specific grand challenge. Participants, along with a director, organizers, subject matter guides, and KI facilitators communally explore the problem space, generate a broad range of ideas, and form transdisciplinary teams to pursue research projects.

Innovation Lab Group

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Completion of application and baseline assessment.
• Faculty at a NIH CTSA hub institution or regional partner.
• Early stage investigators (NIH-defined as "within 10 years of completing his/her terminal research degree or is within 10 years of completing medical residency (or the equivalent)") who are emerging as independent scholars.
• Ratings of goodness of fit with the topic of the Innovation Lab. Applications were reviewed for the above criteria and ranked by committee according to goodness of fit with the topic of the Innovation Lab, the quality and quantity of academic productivity and collaboration, and contribution to diversity of perspectives among Lab participants (e.g., biomedical and social/psychological, basic and applied). Top-ranked applicants were retained for randomization to the Innovation Lab group or control group.

Sponsors & Collaborators

• State University of New York at Buffalo: lead
• National Center for Advancing Translational Sciences (NCATS): collaborator

Study Sites (1)

University at Buffalo

Buffalo, New York, 14260, United States

Location

Related Publications (1)

• Hawk LW Jr, Murphy TF, Hartmann KE, Burnett A, Maguin E. A randomized controlled trial of a team science intervention to enhance collaboration readiness and behavior among early career scholars in the Clinical and Translational Science Award network. J Clin Transl Sci. 2023 Dec 14;8(1):e6. doi: 10.1017/cts.2023.692. eCollection 2024.

  PMID: 38384923 RESULT

MeSH Terms

Conditions

Behavior

Results Point of Contact

• Title: Larry Hawk
• Organization: University at Buffalo

lhawk@buffalo.edu

716-645-0192

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: May 19, 2022
• First Posted: May 27, 2022
• Study Start: August 3, 2017
• Primary Completion: July 12, 2019
• Study Completion: June 25, 2020
• Last Updated: April 27, 2026
• Results First Posted: April 27, 2026

Record last verified: 2026-03

Locations

US (1)